Pharmafile Logo

Impetus Digital official statement on COVID-19

At Impetus Digital, the health and wellbeing of our staff, clients, advisors, and their families is always our top priority. Recently, we have seen high numbers of advisors cancel their attendance for in-person meetings and ask to dial in remotely instead. This is a good thing, as evidence shows that social distancing will be key to flatten the curve and slow the spread of COVID-19.

We are big advocates for both public health and maintaining a viable economy. Therefore, we are strongly encouraging our clients to transfer their upcoming in-person meetings to virtual ones, either using synchronous web meetings, asynchronous touchpoints, or both. This is particularly relevant for large groups or if traveling is required, especially since many international travel restrictions are currently being enforced.

To do our part in keeping the population and economy healthy in these uncertain times, Impetus will waive cancellation fees for any new virtual consultancy, working group, medical education, or internal team meeting that is planned with us. This way, you can rest assured that if you need to quickly set up a virtual meeting in lieu of an in-person meeting, you will not be charged if you need to cancel it for whatever reason.

For more information on our different options for virtual meetings, please visit our website www.impetusdigital.com or make an appointment with Natalie Yeadon at www.meetwithnatalie.com to discuss your needs.

We are always respectfully here to serve our clients, especially during this time of tumult and uncertainty.

Stay safe and healthy,

The Impetus Team

This content was provided by Impetus Digital

Documents for download:

Company Details

 Latest Content from  Impetus Digital 

Impact of the Pandemic on Medical and Scientific Affairs

Dr. Shurjeel Choudhri, SVP and Head, Medical and Scientific Affairs at Bayer Canada, dives into a range of hot topics, from innovative digital technologies and beyond-the-pill medicine to the concept of patient-centricity....

Patient Partnerships: Challenges and Opportunities for Pharma

Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital, for this live Fireside Chat. Today, we are exploring...

Top 10 Tips for Creating Company Culture in a Virtual World

Remote work is here to stay. Learn how companies and employees can thrive in this new environment

Strategies to Launch and Commercialize Healthcare Innovations

Dr. Roxie Mooney, Healthcare Commercialization Strategist at Legacy DNA and best-selling author, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital. We are discussing all things healthcare innovation and commercialization,...

Patient-Centered Digital Transformation

Lygeia Ricciardi, Advisor at Carium, joins Natalie Yeadon, Co-Founder & CEO at Impetus Digital in this Fireside Chat. They explore a variety of topics related to patient-centric care, digital health transformation,...

Effects of the Pandemic on Evidence Generation & Scientific Exchange

Farah Husein, Director, Evidence Generation, Canadian Centre of Excellence, at Takeda, discusses all things evidence generation, including the impact of the COVID-19 pandemic on HEOR, RWE, epidemiology, and PRO studies and...

Press release: InSite Eventâ„¢ named one of the most innovative services of 2020

Press ReleaseContact: Jess Masciangelo, Business Development Directorjmasciangelo@impetusdigital.commeetwithimpetus.comINSITE EVENT™ NAMED ONE OF THE MOST INNOVATIVE SERVICES OF 2020Toronto, ON, December 10, 2020 — Impetus Digital’s new virtual event platform InSite Event™...

The Future of Wearable and Implantable Devices

Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....

Designing Ethical AI and Healthcare Technologies

Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...

Attacking COVID-19 from All Angles

Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...